Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Calcitonin
Therapeutic Area : Endocrinology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Leucadia Pharmaceuticals Launches Calcitonin Salmon Injection
Details : The Calcitonin Salmon injection is therapeutically equivalent or generic of MIACALCIN® and is indicated for the early treatment of hypercalcemic emergencies when a rapid decrease in serum calcium is required.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
May 17, 2021
Lead Product(s) : Calcitonin
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?